nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—CYP1B1—Mitoxantrone—lymphatic system cancer	0.17	0.208	CbGbCtD
Ketoconazole—ABCB11—Vincristine—lymphatic system cancer	0.117	0.143	CbGbCtD
Ketoconazole—CYP1A2—Carmustine—lymphatic system cancer	0.0708	0.0869	CbGbCtD
Ketoconazole—CYP3A5—Teniposide—lymphatic system cancer	0.0639	0.0785	CbGbCtD
Ketoconazole—CYP2C19—Teniposide—lymphatic system cancer	0.0515	0.0633	CbGbCtD
Ketoconazole—SLCO1A2—Methotrexate—lymphatic system cancer	0.0448	0.0551	CbGbCtD
Ketoconazole—CYP2C9—Teniposide—lymphatic system cancer	0.0428	0.0527	CbGbCtD
Ketoconazole—CYP3A7—Vincristine—lymphatic system cancer	0.041	0.0504	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.041	0.0504	CbGbCtD
Ketoconazole—CYP3A5—Vincristine—lymphatic system cancer	0.0308	0.0378	CbGbCtD
Ketoconazole—ABCB1—Mitoxantrone—lymphatic system cancer	0.0291	0.0357	CbGbCtD
Ketoconazole—CYP3A4—Cytarabine—lymphatic system cancer	0.0253	0.0311	CbGbCtD
Ketoconazole—CYP3A4—Teniposide—lymphatic system cancer	0.0249	0.0306	CbGbCtD
Ketoconazole—ABCB1—Vincristine—lymphatic system cancer	0.02	0.0246	CbGbCtD
Ketoconazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0174	0.0214	CbGbCtD
Ketoconazole—ABCB1—Methotrexate—lymphatic system cancer	0.0121	0.0149	CbGbCtD
Ketoconazole—CYP3A4—Vincristine—lymphatic system cancer	0.012	0.0147	CbGbCtD
Ketoconazole—Chills—Fludarabine—lymphatic system cancer	0.000974	0.00523	CcSEcCtD
Ketoconazole—Arrhythmia—Fludarabine—lymphatic system cancer	0.00097	0.00521	CcSEcCtD
Ketoconazole—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.000965	0.00518	CcSEcCtD
Ketoconazole—Leukopenia—Teniposide—lymphatic system cancer	0.000962	0.00517	CcSEcCtD
Ketoconazole—Alopecia—Fludarabine—lymphatic system cancer	0.000959	0.00515	CcSEcCtD
Ketoconazole—Malnutrition—Fludarabine—lymphatic system cancer	0.000945	0.00508	CcSEcCtD
Ketoconazole—Burning sensation—Methotrexate—lymphatic system cancer	0.000922	0.00495	CcSEcCtD
Ketoconazole—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000877	0.00471	CcSEcCtD
Ketoconazole—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000877	0.00471	CcSEcCtD
Ketoconazole—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000859	0.00461	CcSEcCtD
Ketoconazole—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.000853	0.00458	CcSEcCtD
Ketoconazole—Malaise—Fludarabine—lymphatic system cancer	0.000852	0.00458	CcSEcCtD
Ketoconazole—Leukopenia—Fludarabine—lymphatic system cancer	0.000846	0.00454	CcSEcCtD
Ketoconazole—Pruritus—Mechlorethamine—lymphatic system cancer	0.000842	0.00452	CcSEcCtD
Ketoconazole—Anorexia—Teniposide—lymphatic system cancer	0.000836	0.00449	CcSEcCtD
Ketoconazole—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.00083	0.00446	CcSEcCtD
Ketoconazole—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000814	0.00437	CcSEcCtD
Ketoconazole—Arthralgia—Fludarabine—lymphatic system cancer	0.000804	0.00432	CcSEcCtD
Ketoconazole—Myalgia—Fludarabine—lymphatic system cancer	0.000804	0.00432	CcSEcCtD
Ketoconazole—Discomfort—Fludarabine—lymphatic system cancer	0.000795	0.00427	CcSEcCtD
Ketoconazole—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000771	0.00414	CcSEcCtD
Ketoconazole—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000763	0.0041	CcSEcCtD
Ketoconazole—Decreased appetite—Teniposide—lymphatic system cancer	0.000763	0.0041	CcSEcCtD
Ketoconazole—Vomiting—Mechlorethamine—lymphatic system cancer	0.000757	0.00406	CcSEcCtD
Ketoconazole—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000756	0.00406	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000756	0.00406	CcSEcCtD
Ketoconazole—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000755	0.00406	CcSEcCtD
Ketoconazole—Rash—Mechlorethamine—lymphatic system cancer	0.00075	0.00403	CcSEcCtD
Ketoconazole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00075	0.00403	CcSEcCtD
Ketoconazole—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000743	0.00399	CcSEcCtD
Ketoconazole—Anorexia—Fludarabine—lymphatic system cancer	0.000735	0.00395	CcSEcCtD
Ketoconazole—Feeling abnormal—Teniposide—lymphatic system cancer	0.000723	0.00388	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000717	0.00385	CcSEcCtD
Ketoconazole—Chills—Bleomycin—lymphatic system cancer	0.000714	0.00384	CcSEcCtD
Ketoconazole—Nausea—Mechlorethamine—lymphatic system cancer	0.000707	0.0038	CcSEcCtD
Ketoconazole—Alopecia—Bleomycin—lymphatic system cancer	0.000703	0.00378	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000703	0.00377	CcSEcCtD
Ketoconazole—Jaundice—Mitoxantrone—lymphatic system cancer	0.000701	0.00377	CcSEcCtD
Ketoconazole—Urticaria—Teniposide—lymphatic system cancer	0.000697	0.00374	CcSEcCtD
Ketoconazole—Abdominal pain—Teniposide—lymphatic system cancer	0.000694	0.00373	CcSEcCtD
Ketoconazole—Body temperature increased—Teniposide—lymphatic system cancer	0.000694	0.00373	CcSEcCtD
Ketoconazole—Erythema—Bleomycin—lymphatic system cancer	0.000693	0.00372	CcSEcCtD
Ketoconazole—Paraesthesia—Fludarabine—lymphatic system cancer	0.000692	0.00372	CcSEcCtD
Ketoconazole—Oedema peripheral—Carmustine—lymphatic system cancer	0.000684	0.00368	CcSEcCtD
Ketoconazole—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000683	0.00367	CcSEcCtD
Ketoconazole—Dyspepsia—Fludarabine—lymphatic system cancer	0.000679	0.00365	CcSEcCtD
Ketoconazole—Decreased appetite—Fludarabine—lymphatic system cancer	0.00067	0.0036	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000666	0.00358	CcSEcCtD
Ketoconazole—Fatigue—Fludarabine—lymphatic system cancer	0.000665	0.00357	CcSEcCtD
Ketoconazole—Pain—Fludarabine—lymphatic system cancer	0.000659	0.00354	CcSEcCtD
Ketoconazole—Constipation—Fludarabine—lymphatic system cancer	0.000659	0.00354	CcSEcCtD
Ketoconazole—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000652	0.0035	CcSEcCtD
Ketoconazole—Eye disorder—Carmustine—lymphatic system cancer	0.000649	0.00349	CcSEcCtD
Ketoconazole—Hypersensitivity—Teniposide—lymphatic system cancer	0.000646	0.00347	CcSEcCtD
Ketoconazole—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000646	0.00347	CcSEcCtD
Ketoconazole—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000643	0.00345	CcSEcCtD
Ketoconazole—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000635	0.00341	CcSEcCtD
Ketoconazole—Asthenia—Teniposide—lymphatic system cancer	0.00063	0.00338	CcSEcCtD
Ketoconazole—Malaise—Bleomycin—lymphatic system cancer	0.000625	0.00336	CcSEcCtD
Ketoconazole—Pruritus—Teniposide—lymphatic system cancer	0.000621	0.00333	CcSEcCtD
Ketoconazole—Arrhythmia—Carmustine—lymphatic system cancer	0.000621	0.00333	CcSEcCtD
Ketoconazole—Leukopenia—Bleomycin—lymphatic system cancer	0.00062	0.00333	CcSEcCtD
Ketoconazole—Alopecia—Carmustine—lymphatic system cancer	0.000614	0.0033	CcSEcCtD
Ketoconazole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00061	0.00327	CcSEcCtD
Ketoconazole—Mental disorder—Carmustine—lymphatic system cancer	0.000609	0.00327	CcSEcCtD
Ketoconazole—Erythema—Carmustine—lymphatic system cancer	0.000605	0.00325	CcSEcCtD
Ketoconazole—Malnutrition—Carmustine—lymphatic system cancer	0.000605	0.00325	CcSEcCtD
Ketoconazole—Angiopathy—Vincristine—lymphatic system cancer	0.000602	0.00323	CcSEcCtD
Ketoconazole—Diarrhoea—Teniposide—lymphatic system cancer	0.0006	0.00322	CcSEcCtD
Ketoconazole—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000598	0.00321	CcSEcCtD
Ketoconazole—Myalgia—Bleomycin—lymphatic system cancer	0.00059	0.00317	CcSEcCtD
Ketoconazole—Alopecia—Vincristine—lymphatic system cancer	0.000586	0.00315	CcSEcCtD
Ketoconazole—Discomfort—Bleomycin—lymphatic system cancer	0.000583	0.00313	CcSEcCtD
Ketoconazole—Mental disorder—Vincristine—lymphatic system cancer	0.000581	0.00312	CcSEcCtD
Ketoconazole—Chills—Mitoxantrone—lymphatic system cancer	0.000579	0.00311	CcSEcCtD
Ketoconazole—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000577	0.0031	CcSEcCtD
Ketoconazole—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000573	0.00308	CcSEcCtD
Ketoconazole—Alopecia—Mitoxantrone—lymphatic system cancer	0.000571	0.00307	CcSEcCtD
Ketoconazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000568	0.00305	CcSEcCtD
Ketoconazole—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000565	0.00304	CcSEcCtD
Ketoconazole—Erythema—Mitoxantrone—lymphatic system cancer	0.000562	0.00302	CcSEcCtD
Ketoconazole—Vomiting—Teniposide—lymphatic system cancer	0.000558	0.003	CcSEcCtD
Ketoconazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000554	0.00297	CcSEcCtD
Ketoconazole—Asthenia—Fludarabine—lymphatic system cancer	0.000553	0.00297	CcSEcCtD
Ketoconazole—Rash—Teniposide—lymphatic system cancer	0.000553	0.00297	CcSEcCtD
Ketoconazole—Dermatitis—Teniposide—lymphatic system cancer	0.000553	0.00297	CcSEcCtD
Ketoconazole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000551	0.00296	CcSEcCtD
Ketoconazole—Headache—Teniposide—lymphatic system cancer	0.00055	0.00295	CcSEcCtD
Ketoconazole—Pruritus—Fludarabine—lymphatic system cancer	0.000546	0.00293	CcSEcCtD
Ketoconazole—Leukopenia—Carmustine—lymphatic system cancer	0.000541	0.00291	CcSEcCtD
Ketoconazole—Anorexia—Bleomycin—lymphatic system cancer	0.000539	0.00289	CcSEcCtD
Ketoconazole—Photosensitivity—Methotrexate—lymphatic system cancer	0.00053	0.00285	CcSEcCtD
Ketoconazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.000528	0.00283	CcSEcCtD
Ketoconazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000522	0.0028	CcSEcCtD
Ketoconazole—Nausea—Teniposide—lymphatic system cancer	0.000521	0.0028	CcSEcCtD
Ketoconazole—Hepatic failure—Methotrexate—lymphatic system cancer	0.000518	0.00278	CcSEcCtD
Ketoconazole—Leukopenia—Vincristine—lymphatic system cancer	0.000517	0.00278	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000515	0.00277	CcSEcCtD
Ketoconazole—Myalgia—Carmustine—lymphatic system cancer	0.000515	0.00277	CcSEcCtD
Ketoconazole—Paraesthesia—Bleomycin—lymphatic system cancer	0.000508	0.00273	CcSEcCtD
Ketoconazole—Malaise—Mitoxantrone—lymphatic system cancer	0.000507	0.00272	CcSEcCtD
Ketoconazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000503	0.0027	CcSEcCtD
Ketoconazole—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000493	0.00265	CcSEcCtD
Ketoconazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.000491	0.00264	CcSEcCtD
Ketoconazole—Myalgia—Vincristine—lymphatic system cancer	0.000491	0.00264	CcSEcCtD
Ketoconazole—Vomiting—Fludarabine—lymphatic system cancer	0.00049	0.00263	CcSEcCtD
Ketoconazole—Rash—Fludarabine—lymphatic system cancer	0.000486	0.00261	CcSEcCtD
Ketoconazole—Dermatitis—Fludarabine—lymphatic system cancer	0.000486	0.00261	CcSEcCtD
Ketoconazole—Pain—Bleomycin—lymphatic system cancer	0.000483	0.0026	CcSEcCtD
Ketoconazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000483	0.0026	CcSEcCtD
Ketoconazole—Headache—Fludarabine—lymphatic system cancer	0.000483	0.00259	CcSEcCtD
Ketoconazole—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000481	0.00258	CcSEcCtD
Ketoconazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.000479	0.00257	CcSEcCtD
Ketoconazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000479	0.00257	CcSEcCtD
Ketoconazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000473	0.00254	CcSEcCtD
Ketoconazole—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000471	0.00253	CcSEcCtD
Ketoconazole—Anorexia—Carmustine—lymphatic system cancer	0.00047	0.00253	CcSEcCtD
Ketoconazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000466	0.0025	CcSEcCtD
Ketoconazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.000462	0.00248	CcSEcCtD
Ketoconazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000461	0.00248	CcSEcCtD
Ketoconazole—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000459	0.00246	CcSEcCtD
Ketoconazole—Nausea—Fludarabine—lymphatic system cancer	0.000458	0.00246	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00045	0.00242	CcSEcCtD
Ketoconazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000449	0.00241	CcSEcCtD
Ketoconazole—Urticaria—Bleomycin—lymphatic system cancer	0.000449	0.00241	CcSEcCtD
Ketoconazole—Anorexia—Vincristine—lymphatic system cancer	0.000449	0.00241	CcSEcCtD
Ketoconazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000447	0.0024	CcSEcCtD
Ketoconazole—Insomnia—Carmustine—lymphatic system cancer	0.000446	0.0024	CcSEcCtD
Ketoconazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000446	0.00239	CcSEcCtD
Ketoconazole—Paraesthesia—Carmustine—lymphatic system cancer	0.000443	0.00238	CcSEcCtD
Ketoconazole—Somnolence—Carmustine—lymphatic system cancer	0.000439	0.00236	CcSEcCtD
Ketoconazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000437	0.00235	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000429	0.00231	CcSEcCtD
Ketoconazole—Decreased appetite—Carmustine—lymphatic system cancer	0.000429	0.0023	CcSEcCtD
Ketoconazole—Insomnia—Vincristine—lymphatic system cancer	0.000426	0.00229	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000426	0.00229	CcSEcCtD
Ketoconazole—Paraesthesia—Vincristine—lymphatic system cancer	0.000423	0.00227	CcSEcCtD
Ketoconazole—Pain—Carmustine—lymphatic system cancer	0.000422	0.00227	CcSEcCtD
Ketoconazole—Constipation—Carmustine—lymphatic system cancer	0.000422	0.00227	CcSEcCtD
Ketoconazole—Breast disorder—Methotrexate—lymphatic system cancer	0.00042	0.00226	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000418	0.00225	CcSEcCtD
Ketoconazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000417	0.00224	CcSEcCtD
Ketoconazole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000412	0.00221	CcSEcCtD
Ketoconazole—Decreased appetite—Vincristine—lymphatic system cancer	0.00041	0.0022	CcSEcCtD
Ketoconazole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000408	0.00219	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000407	0.00218	CcSEcCtD
Ketoconazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000407	0.00218	CcSEcCtD
Ketoconazole—Fatigue—Vincristine—lymphatic system cancer	0.000406	0.00218	CcSEcCtD
Ketoconazole—Asthenia—Bleomycin—lymphatic system cancer	0.000406	0.00218	CcSEcCtD
Ketoconazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000404	0.00217	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000404	0.00217	CcSEcCtD
Ketoconazole—Pain—Vincristine—lymphatic system cancer	0.000403	0.00216	CcSEcCtD
Ketoconazole—Constipation—Vincristine—lymphatic system cancer	0.000403	0.00216	CcSEcCtD
Ketoconazole—Pruritus—Bleomycin—lymphatic system cancer	0.0004	0.00215	CcSEcCtD
Ketoconazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000399	0.00214	CcSEcCtD
Ketoconazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000396	0.00212	CcSEcCtD
Ketoconazole—Pain—Mitoxantrone—lymphatic system cancer	0.000392	0.00211	CcSEcCtD
Ketoconazole—Constipation—Mitoxantrone—lymphatic system cancer	0.000392	0.00211	CcSEcCtD
Ketoconazole—Abdominal pain—Carmustine—lymphatic system cancer	0.00039	0.0021	CcSEcCtD
Ketoconazole—Body temperature increased—Carmustine—lymphatic system cancer	0.00039	0.0021	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000385	0.00207	CcSEcCtD
Ketoconazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000378	0.00203	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000375	0.00202	CcSEcCtD
Ketoconazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000372	0.002	CcSEcCtD
Ketoconazole—Body temperature increased—Vincristine—lymphatic system cancer	0.000372	0.002	CcSEcCtD
Ketoconazole—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00037	0.00199	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000367	0.00197	CcSEcCtD
Ketoconazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000364	0.00196	CcSEcCtD
Ketoconazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000364	0.00195	CcSEcCtD
Ketoconazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000363	0.00195	CcSEcCtD
Ketoconazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000363	0.00195	CcSEcCtD
Ketoconazole—Vomiting—Bleomycin—lymphatic system cancer	0.000359	0.00193	CcSEcCtD
Ketoconazole—Rash—Bleomycin—lymphatic system cancer	0.000356	0.00191	CcSEcCtD
Ketoconazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000356	0.00191	CcSEcCtD
Ketoconazole—Asthenia—Carmustine—lymphatic system cancer	0.000354	0.0019	CcSEcCtD
Ketoconazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000347	0.00186	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000339	0.00182	CcSEcCtD
Ketoconazole—Epistaxis—Methotrexate—lymphatic system cancer	0.000338	0.00182	CcSEcCtD
Ketoconazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000338	0.00182	CcSEcCtD
Ketoconazole—Asthenia—Vincristine—lymphatic system cancer	0.000338	0.00182	CcSEcCtD
Ketoconazole—Diarrhoea—Carmustine—lymphatic system cancer	0.000338	0.00181	CcSEcCtD
Ketoconazole—Nausea—Bleomycin—lymphatic system cancer	0.000336	0.0018	CcSEcCtD
Ketoconazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000329	0.00177	CcSEcCtD
Ketoconazole—Dizziness—Carmustine—lymphatic system cancer	0.000326	0.00175	CcSEcCtD
Ketoconazole—Diarrhoea—Vincristine—lymphatic system cancer	0.000322	0.00173	CcSEcCtD
Ketoconazole—Hepatitis—Methotrexate—lymphatic system cancer	0.000322	0.00173	CcSEcCtD
Ketoconazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000314	0.00169	CcSEcCtD
Ketoconazole—Vomiting—Carmustine—lymphatic system cancer	0.000314	0.00169	CcSEcCtD
Ketoconazole—Dizziness—Vincristine—lymphatic system cancer	0.000312	0.00167	CcSEcCtD
Ketoconazole—Rash—Carmustine—lymphatic system cancer	0.000311	0.00167	CcSEcCtD
Ketoconazole—Dermatitis—Carmustine—lymphatic system cancer	0.000311	0.00167	CcSEcCtD
Ketoconazole—Headache—Carmustine—lymphatic system cancer	0.000309	0.00166	CcSEcCtD
Ketoconazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000304	0.00163	CcSEcCtD
Ketoconazole—Eye disorder—Methotrexate—lymphatic system cancer	0.000301	0.00162	CcSEcCtD
Ketoconazole—Vomiting—Vincristine—lymphatic system cancer	0.0003	0.00161	CcSEcCtD
Ketoconazole—Rash—Vincristine—lymphatic system cancer	0.000297	0.0016	CcSEcCtD
Ketoconazole—Dermatitis—Vincristine—lymphatic system cancer	0.000297	0.00159	CcSEcCtD
Ketoconazole—Headache—Vincristine—lymphatic system cancer	0.000295	0.00159	CcSEcCtD
Ketoconazole—Nausea—Carmustine—lymphatic system cancer	0.000293	0.00157	CcSEcCtD
Ketoconazole—Angiopathy—Methotrexate—lymphatic system cancer	0.000292	0.00157	CcSEcCtD
Ketoconazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000292	0.00157	CcSEcCtD
Ketoconazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000291	0.00156	CcSEcCtD
Ketoconazole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00029	0.00156	CcSEcCtD
Ketoconazole—Rash—Mitoxantrone—lymphatic system cancer	0.000289	0.00155	CcSEcCtD
Ketoconazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000289	0.00155	CcSEcCtD
Ketoconazole—Chills—Methotrexate—lymphatic system cancer	0.000289	0.00155	CcSEcCtD
Ketoconazole—Headache—Mitoxantrone—lymphatic system cancer	0.000287	0.00154	CcSEcCtD
Ketoconazole—Alopecia—Methotrexate—lymphatic system cancer	0.000284	0.00153	CcSEcCtD
Ketoconazole—Mental disorder—Methotrexate—lymphatic system cancer	0.000282	0.00151	CcSEcCtD
Ketoconazole—Erythema—Methotrexate—lymphatic system cancer	0.00028	0.0015	CcSEcCtD
Ketoconazole—Malnutrition—Methotrexate—lymphatic system cancer	0.00028	0.0015	CcSEcCtD
Ketoconazole—Nausea—Vincristine—lymphatic system cancer	0.00028	0.0015	CcSEcCtD
Ketoconazole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000274	0.00147	CcSEcCtD
Ketoconazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000273	0.00146	CcSEcCtD
Ketoconazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00026	0.0014	CcSEcCtD
Ketoconazole—Malaise—Methotrexate—lymphatic system cancer	0.000253	0.00136	CcSEcCtD
Ketoconazole—Leukopenia—Methotrexate—lymphatic system cancer	0.000251	0.00135	CcSEcCtD
Ketoconazole—Arthralgia—Methotrexate—lymphatic system cancer	0.000238	0.00128	CcSEcCtD
Ketoconazole—Myalgia—Methotrexate—lymphatic system cancer	0.000238	0.00128	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000237	0.00127	CcSEcCtD
Ketoconazole—Discomfort—Methotrexate—lymphatic system cancer	0.000236	0.00127	CcSEcCtD
Ketoconazole—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000229	0.00123	CcSEcCtD
Ketoconazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000224	0.0012	CcSEcCtD
Ketoconazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000224	0.0012	CcSEcCtD
Ketoconazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000222	0.00119	CcSEcCtD
Ketoconazole—Anorexia—Methotrexate—lymphatic system cancer	0.000218	0.00117	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000208	0.00112	CcSEcCtD
Ketoconazole—Insomnia—Methotrexate—lymphatic system cancer	0.000207	0.00111	CcSEcCtD
Ketoconazole—Paraesthesia—Methotrexate—lymphatic system cancer	0.000205	0.0011	CcSEcCtD
Ketoconazole—Somnolence—Methotrexate—lymphatic system cancer	0.000203	0.00109	CcSEcCtD
Ketoconazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000201	0.00108	CcSEcCtD
Ketoconazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000199	0.00107	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000197	0.00106	CcSEcCtD
Ketoconazole—Fatigue—Methotrexate—lymphatic system cancer	0.000197	0.00106	CcSEcCtD
Ketoconazole—Pain—Methotrexate—lymphatic system cancer	0.000195	0.00105	CcSEcCtD
Ketoconazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000188	0.00101	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000187	0.001	CcSEcCtD
Ketoconazole—Urticaria—Methotrexate—lymphatic system cancer	0.000182	0.000975	CcSEcCtD
Ketoconazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000181	0.000971	CcSEcCtD
Ketoconazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000181	0.000971	CcSEcCtD
Ketoconazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000168	0.000905	CcSEcCtD
Ketoconazole—Asthenia—Methotrexate—lymphatic system cancer	0.000164	0.000881	CcSEcCtD
Ketoconazole—Pruritus—Methotrexate—lymphatic system cancer	0.000162	0.000869	CcSEcCtD
Ketoconazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000156	0.00084	CcSEcCtD
Ketoconazole—Dizziness—Methotrexate—lymphatic system cancer	0.000151	0.000812	CcSEcCtD
Ketoconazole—Vomiting—Methotrexate—lymphatic system cancer	0.000145	0.000781	CcSEcCtD
Ketoconazole—Rash—Methotrexate—lymphatic system cancer	0.000144	0.000774	CcSEcCtD
Ketoconazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000144	0.000773	CcSEcCtD
Ketoconazole—Headache—Methotrexate—lymphatic system cancer	0.000143	0.000769	CcSEcCtD
Ketoconazole—Nausea—Methotrexate—lymphatic system cancer	0.000136	0.000729	CcSEcCtD
